Paid Clinical Trials in Santa Rosa, CA
As of September 2026, 104 paid clinical trials are recruiting in Santa Rosa, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Santa Rosa offers studies at sites including Kaiser Permanente-Santa Rosa for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Endometrial Cancer, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Santa Rosa
Trials by drug in Santa Rosa
Filter results
103 clinical trials
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Galleri® in the Medicare Population.
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Patient Specific Talus Spacer Post Approval Study
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Top Research Study Locations in Santa Rosa
Researchers run research studies in Santa Rosa, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Kaiser Permanente-Santa Rosa | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Acute Myeloid Leukemia | 28 |
| Providence Medical Foundation - Santa Rosa | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Malignant Solid Neoplasm | 27 |
| Providence Santa Rosa Memorial Hospital | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Ovarian Carcinoma | 24 |
| Sutter Pacific Medical Foundation | Anatomic Stage II Breast Cancer AJCC v8, Metastatic Renal Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | 18 |
| Providence Medical Foundation | Colorectal Neoplasms, Endometrial Cancer, Fallopian Tube Cancer | 16 |
| NorthBay Clinical Research | Atherosclerosis, Heart Failure, Obesity | 4 |
| Providence Medical Group | Anemia, Metastatic Solid Tumors, Myelodysplastic Syndrome | 2 |
| Sutter Health Santa Rosa | Avascular Necrosis of the Talus, Cancer | 2 |
| Airway Drive Care Center | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| Kaiser Permanente Santa Rosa Emergency Department | Heart Failure | 1 |
| Kaiser Permanente Santa Rosa Med | Lumbar Spinal Stenosis | 1 |
| Laservue Eye Center | Lumbar Spinal Stenosis | 1 |
| NGM Clinical Study Site | CRC (Colorectal Cancer), Cancer Cachexia, Colorectal Cancer | 1 |
| NorthBay Clinical Research LLC | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| NorthBay Clinical Research, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Northbay Clinical Research Center | Atrial Fibrillation (AF) | 1 |
| Pacific Restorative Center | Lumbar Spinal Stenosis | 1 |
| Providence Medical Foundation (St. Joseph Heritage Healthcare) | Non-small Cell Lung Cancer (NSCLC) | 1 |
| Providence Medical Foundation - Santa Rosa, CA | Metastatic Breast Cancer | 1 |
| Providence Medical Foundation 1 | Carcinoma, Non-Small-Cell Lung | 1 |
| Providence Medical Group - Santa Rosa | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Providence Medical Group Oncology Santa Rosa | Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer, Prostate Cancer | 1 |
| Santa Rosa Memorial Hospital | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
Active & Upcoming Studies in Santa Rosa (2026)
Recruiting trials in Santa Rosa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (76 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Diabetes & metabolic (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Common conditions studied in Santa Rosa
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- Breast Cancer (3 active studies)
- Colorectal Neoplasms (3 active studies)
Leading research sponsors in Santa Rosa
- SWOG Cancer Research Network
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Santa Rosa?
There are approximately 104 recruiting clinical trials in Santa Rosa, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Santa Rosa pay participants?
Most recruiting trials in Santa Rosa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Santa Rosa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Santa Rosa?
The most common conditions under active study in Santa Rosa include Anatomic Stage II Breast Cancer AJCC v8 (4), Endometrial Cancer (4), Lung Non-Small Cell Carcinoma (4), Acute Myeloid Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Santa Rosa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Santa Rosa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Santa Rosa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Santa Rosa?
Recruiting research sites in Santa Rosa include Kaiser Permanente-Santa Rosa, Providence Medical Foundation - Santa Rosa, Providence Santa Rosa Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Santa Rosa right now?
The largest active categories in Santa Rosa are Cancer & tumors (76), Cardiovascular (6), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.